In the Boardroom
Refine Search
Biotechnology
US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief executive (CEO). In this newly-created role, Ms High will lead the team’s continued efforts to propel the development of a pipeline of transformative therapies and accelerate their potential impact. 22 November 2024
Biotechnology
US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, effective December 16, 2024. 21 November 2024
Biotechnology
Mirai Bio has announced the appointment of Jens Vogel as the company’s president and chief operating officer (COO). 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Privately-held US biotech Georgiamune has announced the appointment of Mark Avagliano as chief business officer (CBO). 19 November 2024
Biotechnology
Belgian biotech start-up ExeVir Bio says it has appointed Michael Garrett as its new chief executive (CEO), effective 1 December 2024. 18 November 2024
Biotechnology
ALX Oncology Holdings, a Californian immuno-oncology company, has announced the appointment of Alan Sandler as chief medical officer (CMO). 14 November 2024
Biotechnology
VarmX, a Dutch biotech developing innovative approaches for the bypass of direct oral anticoagulants targeting activated factor Xa (FXa DOACs) and inherited coagulation disorders, has appointed industry veteran John Glasspool (pictured, above) as chief executive. 12 November 2024
Biotechnology
French biotech DiogenX, which is focused on regenerating insulin-producing beta cells for the treatment of diabetes, today announces the appointment of Dr Klara Owen as chief medical officer. 12 November 2024
Biotechnology
Rubedo Life Sciences, a US biopharma developing first-in-class therapies targeting senescent cells which drive age-related diseases, has announced the appointment of Frederick C Beddingfield III, as chief executive officer and board director. 11 November 2024
Biotechnology
US clinical-stage drug developer Acumen Pharmaceuticals has appointed Amy Schacterle as chief regulatory officer and head of quality, reporting to Jim Doherty, president and chief development officer at Acumen. 7 November 2024
Biotechnology
Memo Therapeutics, a privately-held Swiss biotech company translating unique responses into superior medicines to treat viral infections and cancer, has appointed a new chief development officer (CDO). 4 November 2024
Biotechnology
Netherlands-based Tessellate BIO, a pre-clinical stage biotech with a focus on novel synthetic lethality approaches, today announced the appointment of Dr Lara Boyd as chief business officer. 4 November 2024
Biotechnology
US biotech major Biogen revealed it has appointed Daniel Quirk as chief medical officer and head of medical affairs. 29 October 2024
Biotechnology
AAVantgarde has announced the appointment of Lauren Kaskiel as chief business officer (CBO). 22 October 2024
Biotechnology
Denmark’s Commit Biologics, a specialist in the activation of the complement system to treat cancer and autoimmune disease, has announced the appointment of Mikkel Wandahl Pedersen as chief scientific officer (CSO). 15 October 2024
Biotechnology
French biotech Innate Pharma has appointed Jonathan Dickinson as its new chief executive (CEO) and chairman of the executive board, effective November 1, 2024. 14 October 2024
Biotechnology
Turnstone Biologics has announced a major restructuring of its operations, cutting its workforce by approximately 60%. 14 October 2024
Biotechnology
Calluna Pharma, a biotech focused on treating inflammatory and fibrotic diseases, has appointed Mark Gaffney as its new chief executive. 9 October 2024
Biotechnology
Privately-held UK biotech Curve Therapeutics has announced the appointment of Rab Prinjha as chief research and development (R&D) officer. 9 October 2024
Biotechnology
Jeffrey Barrett has been appointed the founding director for the Centre for Therapeutic Target Validation, a public-private partnership between GlaxoSmithKline, the European Bioinformatics Institute and the Wellcome Trust Sanger Institute. 2 March 2015
Biotechnology
Kymab, a pharma company based in Cambridge, UK, focusing on monoclonal antibodies, has appointed Anne Hyland as chief financial officer. 19 February 2015
Biotechnology
US biotech major Gilead Sciences has promoted Andrew Cheng to executive vice president of HIV therapeutics and development operations, and Taiyin Yang to executive vice president of pharmaceutical development and manufacturing. 29 January 2015
Biotechnology
Drug delivery and dosage specialist EastGate Biotech Corp has appointed Rose Perri as president. 21 January 2015
Biotechnology
AiCuris, a company formed by experts from Bayer's virology and bacteriology research divisions, is to have a lineup change in its senior management. 21 January 2015
Biotechnology
Immunotherapy specialist Immune Therapeutics has appointed Seth Elliott as president and chief operating officer. 14 January 2015
Biotechnology
Dutch gene therapy specialist uniQure has appointed Matthew Kapusta as chief financial officer. 9 January 2015
Biotechnology
Isis Pharma, the biopharma Crohn’s disease specialist, has appointed Sarah Boyce to the newly-created chief business officer position. 7 January 2015
Biotechnology
Oncology biotech company CytomX has appointed Michael Kavanaugh as chief scientific officer and head of research and early development. 5 January 2015
Biotechnology
Immunotherapeutic company PDS Biotechnology has made Richard Sykes executive chairman of its board of directors. 18 December 2014
Biotechnology
Genetic diagnostic lab, Claritas Genomics, has appointed Patrick Terry as chief commercial officer. 18 December 2014
Biotechnology
US biotech company Celgene Corp has made two appointments to its EMEA team. 18 December 2014
Biotechnology
US biotech major Gilead Sciences has appointed Philippe Bishop as senior vice president of hematology and oncology therapeutics. 15 December 2014
Biotechnology
Denmark-based biotech company Zealand Pharma announced today that senior vice president and chief business officer, Arvind Hundal, has stepped down to pursue other opportunities outside the company. 15 December 2014
Biotechnology
The co-founder of Dutch nanomedicine company Cristal Therapeutics, Joost Holthuis, has succeeded its founder Cristianne Rijcken as chief executive of the company. 15 December 2014
Biotechnology
RNA therapy specialist RaNA Therapeutics has appointed Ronald Renaud as chief executive. 11 December 2014
Biotechnology
Biopharma commpany Ardelyx has appointed Jeremy Caldwell as executive vice president and chief scientific officer. 11 December 2014
Biotechnology
US biotech company Celgene has appointed Wim Souverijns as vice president general manager for the UK and Ireland. 11 December 2014
Biotechnology
Late-stage biopharma company Soligenix has appointed Oreola Donini as senior vice president and chief scientific officer. 10 December 2014
Biotechnology
Synthetic biology company Synthetic Genomics has appointed Oliver Fetzer as the company’s new chief executive. 29 October 2014
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze